BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or...
25 insider purchases on record · latest filing 2025-06-30.
Insiders have also filed 413 sale transactions at BBIO.